 |
(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2011-10-12 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Jersey, 07936 |
